Ahead of the Bell: Neurocrine Biosciences
Published by Live Search News: "Food and Drug Administration" November 7th, 2006 in Regulatory AffairsMSN MoneyCentral - … any disappointing news related to insomnia drug Indiplon would likely be offset by gains from other products. Neurocrine’s stock plunged on Friday after the company said it planned to conduct more studies on Indiplon. The Food and Drug Administration …